Fusion Antibodies Quote - FAB

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

6.70

Bid

6.50

Ask

6.90

Volume

1,857,901

6.55 Day's Range 7.10

2.90 52 Week Range 8.25

Market Cap

6.389M

Previous Close

6.55

Open

6.55

Last Trade

6.8912

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,478,611

Shares Outstanding

95,365,564

Dividend Yield

PE Ratio

-2.88

Earnings Per Share (EPS)

-0.02

Revenue

1.14M

Net Profit

-2.23M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.fusionantibodies.com

Headquarters

Belfast, Gbr

Founded

Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 6.55p. Over the last year, Fusion Antibodies shares have traded in a share price range of 2.90p to 8.25p.

Fusion Antibodies currently has 95,365,564 shares outstanding. The market capitalization of Fusion Antibodies is £6.25 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -2.88.

Fusion Antibodies receives approval of grant funding application

Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...

Fusion Antibodies PLC Approval of Grant Funding Application

Fusion Antibodies PLC 04 December 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies interim loss narrows as revenue more than doubles

Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...

Fusion Antibodies PLC Half-year Report

Fusion Antibodies PLC 19 November 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies PLC Director/PDMR Shareholding

Fusion Antibodies PLC 16 October 2024 16 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Director/PDMR Shareholding Fusion Antibodies plc (AIM: FAB), specialists in...

Fusion Antibodies PLC Issue of shares to non-executive directors

Fusion Antibodies PLC 16 October 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

IN BRIEF: Fusion Antibodies expects interim revenue to double

PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...

Fusion Antibodies PLC Result of AGM

Fusion Antibodies PLC 08 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Result of AGM Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery...

Fusion Antibodies PLC AGM statement and trading update

Fusion Antibodies PLC 08 October 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies PLC Block admission six monthly return

Fusion Antibodies PLC 02 October 2024 2 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Block admission six monthly return Fusion Antibodies plc (AIM: FAB), specialists...

Fusion Antibodies receives approval of grant funding application

Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...

Fusion Antibodies PLC Approval of Grant Funding Application

Fusion Antibodies PLC 04 December 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies interim loss narrows as revenue more than doubles

Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...

Fusion Antibodies PLC Half-year Report

Fusion Antibodies PLC 19 November 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

Fusion Antibodies PLC Director/PDMR Shareholding

Fusion Antibodies PLC 16 October 2024 16 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Director/PDMR Shareholding Fusion Antibodies plc (AIM: FAB), specialists in...

Fusion Antibodies PLC Issue of shares to non-executive directors

Fusion Antibodies PLC 16 October 2024 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

IN BRIEF: Fusion Antibodies expects interim revenue to double

PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...

Fusion Antibodies PLC Result of AGM

Fusion Antibodies PLC 08 October 2024 Fusion Antibodies plc ("Fusion" or the "Company") Result of AGM Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.2	-2.89855072464	6.9	7.25	6.25	1967149	6.57507552	DE
4	2.5	59.5238095238	4.2	7.25	4.2	2249904	6.04219054	DE
12	2	42.5531914894	4.7	7.25	3.85	1478611	5.15463689	DE
26	3.5	109.375	3.2	7.25	2.9	1282521	4.40723995	DE
52	2.45	57.6470588235	4.25	8.25	2.9	1183246	4.30097648	DE
156	-113.3	-94.4166666667	120	130	2.9	704153	6.09604965	DE
260	-71.8	-91.4649681529	78.5	250	2.9	438426	10.93949766	DE

FAB - Frequently Asked Questions (FAQ)

What is the current Fusion Antibodies share price?

The current share price of Fusion Antibodies is 6.70p

How many Fusion Antibodies shares are in issue?

Fusion Antibodies has 95,365,564 shares in issue

What is the market cap of Fusion Antibodies?

The market capitalisation of Fusion Antibodies is GBP 6.25M

What is the 1 year trading range for Fusion Antibodies share price?

Fusion Antibodies has traded in the range of 2.90p to 8.25p during the past year

What is the PE ratio of Fusion Antibodies?

The price to earnings ratio of Fusion Antibodies is -2.88

What is the cash to sales ratio of Fusion Antibodies?

The cash to sales ratio of Fusion Antibodies is 5.63

What is the reporting currency for Fusion Antibodies?

Fusion Antibodies reports financial results in GBP

What is the latest annual turnover for Fusion Antibodies?

The latest annual turnover of Fusion Antibodies is GBP 1.14M

What is the latest annual profit for Fusion Antibodies?

The latest annual profit of Fusion Antibodies is GBP -2.23M

What is the registered address of Fusion Antibodies?

The registered address for Fusion Antibodies is 1 SPRINGBANK ROAD, SPRINGBANK INDUSTRIAL ESTATE, DUNMURRY, BELFAST, BT17 0QL

What is the Fusion Antibodies website address?

The website address for Fusion Antibodies is www.fusionantibodies.com

Which industry sector does Fusion Antibodies operate in?

Fusion Antibodies operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TIRTiger Royalties And Investments Plc	0.15p (50.00%)	3.41M
BAYBay Capital Plc	5.50p (19.57%)	209.68k
MASTMast Energy Developments Plc	0.19p (18.75%)	20.09M
MHNMenhaden Resource Efficiency Plc	148.50p (18.33%)	1M
ZENZenith Energy Ltd.	2.50p (16.28%)	3.93M
TRYBTribe Technology Plc	0.115p (-79.09%)	24.27M
NMTNeometals Ltd	2.75p (-35.29%)	49.4k
SNGSynairgen Plc	2.46p (-34.31%)	4.31M
TM1Technology Minerals Plc	0.185p (-26.00%)	174.03M
AYMAnglesey Mining Plc	0.70p (-17.65%)	2.99M
NTVONativo Resources Plc	0.002p (5.26%)	971.94M
TRPTower Resources Plc	0.035p (9.38%)	620.03M
LLOYLloyds Banking Group Plc	54.16p (-0.26%)	341.48M
ORCPOracle Power Plc	0.0255p (-1.92%)	192.93M
TM1Technology Minerals Plc	0.185p (-26.00%)	174.03M